-
EN
EN
Bostal is a global pharmaceutical company driven by advanced drug delivery technologies. The company focuses on the development and commercialization of innovative pharmaceutical products, including 505(b)(2) new drugs and complex formulations, leveraging cutting-edge formulation and drug delivery platforms. Through the full integration of its U.S. subsidiary, Bostal LLC, the company has established a global R&D and manufacturing ecosystem powered by dual capabilities in China and the United States. With advanced technology platforms, an experienced R&D team, rigorous quality management systems, and extensive project management expertise, Bostal is committed to collaborating with global partners to advance pharmaceutical innovation and contribute to improving human health worldwide.
Read More →Longer-lasting, safer and more convenient medicines for human
Bostal has extensive experience in the development of immediate-release oral dosage forms, including but not limit to conventional
tablets, hard capsules, soft capsules, granules, pellet formulations, and dry suspensions. We provide customized, end-to-end
development services covering formulation and process development, process optimization, scale-up, and technology transfer
to commercial manufacturing.
Bostal possesses extensive expertise and proven project experience in the technology development and industrialization commercialization of modified-release oral
dosage forms, including matrix extended-release technology, osmotic pump controlled-release technology, gastro-retentive extended-release technology,
enteric-coated formulations technology, and extended-release pellet technology.
Bostal has extensive experience in the development and manufacturing of both conventional and lyophilized injectable formulations.
We offers integrated technological support for injectable products, including solutions for injection and lyophilized powders for
injection, applicable to covering both conventional drug substances and highly potent active pharmaceutical ingredients （APIs）.
Bostal has established deep extensive expertise in long-acting and complex injectable drug delivery technologies, with comprehensive development
and industrialization technology platforms covering a wide range of advanced injectable formulations, including long-acting injectable microspheres,
long-acting injectable in-situ forming gel, long-acting implants, long-acting nano-suspensions, long-acting injectable lyotropic liquid crystals,
liposome, nanoparticles, and emulsions. Bostal provides possesses comprehensive integrated R&D and commerciali
Bostal has established a comprehensive technology platform for the solubilisation of poorly soluble drugs. With extensive expertise in salt formation,
nanomilling, solid dispersion technologies (including hot-melt extrusion and spray drying), and self-emulsifying/self-microemulsifying drug delivery
technologies, Bostal provides advanced formulation solutions to improve drug solubility and bioavailability.
Bostal has accumulated extensive expertise in the development of topical formulations, with proven capabilities in the research, development,
R&D and commercialization of various topical dosage forms, including ointments, creams, and gels.
Bostal is dedicated to build a "one-stop" drug development and commercialization platform, and provides customers with formulation development, pharmacodynamics, toxicology, clinical, contract manufacture, registration, and a full range of professional services.
Drug Product Development
Analytical Development
Manufacture
Preclinical Study
Clinical Study
Drugs Registration
Best for You
+86 020-22017907, Business Development：+86 180 1173 5755
If you have any suggestions for our work, please contact us and we will give you feedback as soon as possible.
Address:6F, Building C1-C2, No.11 Kaiyuan Road, Guangzhou Science Park, Guangzhou High-tech Industrial Development Zones, Guangzhou, Guangdong, China(510530)
Address:No. 228 Ruixiang Road, Huangpu District, Guangzhou, Guangdong, China(510530)
Phone:+86 020-22017907, Business Development：+86 180 1173 5755
E-mail:bstpv@bostaldrug.com（Adverse Drug Report）
E-mail:BD@bostaldrug.com（Business Consult）